Graduation is approaching for Loyola’s Class of 2026, calling for seniors to reflect on their postgraduate plans.

Over the last year, it seems that every month I struggle to decide what to address in this column. This month has been no ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...

Smaller players can position themselves in niches that may not seem significant now but have explosive growth opportunities ...

Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.

Ecopipam, Emalex’s investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with ...

With recent FDA acceptance of the Phase 2a multidose portion of INLIGHT trial of WVE-007 (INHBE GalNAc-siRNA) in individuals with higher BMI, with and without type 2 diabetes, this portion of the ...

Some experts say we are getting dumber by the way. But while we may be heading towards the Age of Stupid, we aren't there - ...

A new study by scientists from the Leibniz Institute for Zoo and Wildlife Research (Leibniz-IZW) has revealed significant ...

A Montana court just ruled biological sex laws are unconstitutional — and fake academic science is how the Left made it ...

With this transaction, Biogen now owns exclusive worldwide development and commercialization rights to felzartamab, consolidating global rights under one owner -- Advancing felzartamab -- a ...

Volunteers reside in the park and are provided a full hook-up campsite while they serve. Volunteers are the primary point of contact for park visitors. Volunteers greet visitors, provide park ...